Home > Insider Trading > Autolus Therapeutics Plc

Autolus Therapeutics Plc (AUTL)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Autolus Therapeutics plc (NASDAQ:AUTL) Q2 2023 Earnings Call Transcript

Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Second Quarter 2023 Financial Results Conference. At this time, all participants are in a listen-only mode.

Keep Reading →

August 7th, 2023 - News Transcripts

10 Hot Penny Stocks To Buy

Investing in small-cap and micro-cap companies comes with a lot of volatility, surprises and risks.

Keep Reading →

June 4th, 2023 - Hedge Funds News

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2023 Earnings Call Transcript

Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2023 Financial Results Conference Call and Operational Progress.

Keep Reading →

May 9th, 2023 - News Transcripts

12 Best Low-Priced Growth Stocks To Buy

The US stock market is showing signs of unprecedented resilience, defying expectations of several analysts and hedge fund managers, including the Big Short Michael Burry, who recently said in a tweet ...

Keep Reading →

April 16th, 2023 - Hedge Funds News

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, welcome to the Autolus Therapeutics full year 2022 financial results conference call and fourth quarter operational progress.

Keep Reading →

March 8th, 2023 - News Transcripts

5 High Growth UK Stocks to Buy

Adaptimmune Therapeutics plc (NASDAQ:ADAP) is a biotechnology firm that develops tumor and cancer treatments. Some cancers that the firm is taking aim at include those of the lungs, head, and neck.

Keep Reading →

March 1st, 2023 - Hedge Funds News

Why These 5 Stocks Are Trending on Monday

5. Caterpillar Inc. (NYSE:CAT) shares have surged 4% after Mircea Dobre of Baird made the stock a 'fresh pick' and reiterated an 'outperform' rating. Dobre has a $290 price target as Caterpillar Inc.

Keep Reading →

November 8th, 2021 - Market Movers News

Is Autolus Therapeutics (AUTL) Overvalued?

Is Autolus Therapeutics plc (NASDAQ:AUTL) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors...

Keep Reading →

December 4th, 2020 - Hedge Funds News

Hedge Funds Are Buying Autolus Therapeutics plc (AUTL)

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

July 2nd, 2020 - Hedge Funds News